Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (L39467) - R1 - Effective August 22, 2024 Aug 22, 2024
MolDX: Molecular Testing for Solid Organ Allograft Rejection Aug 16, 2024
Noridian Molecular Diagnostic Service New Look Aug 09, 2024
Local Coverage Determinations (LCDs) Finalized - Effective September 22, 2024 Aug 08, 2024
Billing and Coding: MolDX: Afirma™ Assay by Veracyte (A54356) Retirement - Effective July 28, 2024 Aug 01, 2024
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R6 - Effective August 1, 2024 Aug 01, 2024
Billing and Coding MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R19 - Effective August 1, 2024 Aug 01, 2024
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms - Published for Review and Comments Aug 01, 2024
Open Meeting Announcement - MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms - September 13, 2024 Aug 01, 2024
Facet Joint Interventions for Pain Management L38801 - R3 and Billing and Coding: Facet Joint Interventions for Pain Management A58403 - R5 - Effective July 7, 2024 Aug 01, 2024
MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (L38339) - R2 - Effective July 25, 2024 Jul 25, 2024
Self-Administered Drug Exclusion List (A53032) - R37 - Effective July 1, 2024 Jul 18, 2024
Polysomnography and Other Sleep Studies - Published for Review and Comments Jul 18, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R18 - Effective July 1, 2024 Jul 11, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R12 - Effective July 1, 2024 Jul 11, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R7 - Effective July 11, 2024 Jul 11, 2024
Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (A59521) - R2 - Effective July 1, 2024 Jul 11, 2024
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R17 - Effective July 1, 2024 Jul 05, 2024
Self-Administered Drug Exclusion List (A53032) - R36 - Effective July 1, 2024 Jul 05, 2024
Local Coverage Determinations (LCDs) Finalized - Effective August 18, 2024 Jul 05, 2024
Billing and Coding: MolDX: Proteomics Testing (A59641) - R5 - Effective July 1, 2024 Jul 05, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R19 - Effective July 1, 2024 Jul 05, 2024
2024 CPT/HCPCS Local Coverage Article (LCA) Updates Jun 27, 2024
MolDX: Pigmented Lesion Assay (L38151) - R1 - Effective June 20, 2024 Jun 20, 2024
MolDX: Melanoma Risk Stratification Molecular Testing (L37750) - R6 - Effective June 20, 2024 Jun 20, 2024
Local Coverage Determinations (LCDs) Finalized - Effective July 28, 2024 Jun 13, 2024
Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) (A56572) - R6 - Effective January 10, 2021 Jun 13, 2024
Billing and Coding: Epidural Steroid Injections for Pain Management (A58993) - R3 -November 15, 2023 Jun 11, 2024
Billing and Coding: Sacroiliac Joint Injections and Procedures (A59244) - R5 - Effective June 1, 2024 Jun 11, 2024
Billing and Coding: Leadless Pacemakers (A59819) - Effective June 6, 2024 Jun 07, 2024
Billing and Coding: MolDX: Billing and Coding: MolDx: ResponseDX Tissue of Origin (A54494) Retirement - Effective May 30, 2024 Jun 06, 2024
Billing and Coding: MolDX: PAX6 Gene Sequencing (A55625) Retirement - Effective May 29, 2024 Jun 06, 2024
Billing and Coding: MolDX: MMACHC Test (A55288) Retirement - Effective May 30, 2024 Jun 06, 2024
Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests (A55290) Retirement - Effective May 29, 2024 Jun 06, 2024
Billing and Coding: MolDX: CDH1 Genetic Testing (A55970) Retirement - Effective May 30, 2024 Jun 06, 2024
Billing and Coding: MolDX: Proteomics Testing (A59641) - R4 - Effective May 30, 2024 May 30, 2024
Open Meeting Announcement Botulinum Toxin Injections, Micro Invasive Glaucoma Surgery (MIGS), Artificial Intelligence Enabled Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) - June 27, 2024 May 30, 2024
Billing and Coding: MolDX: SMPD1 Genetic Testing (A55627) Retirement - Effective May 21, 2024 May 30, 2024
Billing and Coding: MolDX: MCOLN1 Genetic Testing (A55283) Retirement - Effective May 23, 2024 May 30, 2024
Billing and Coding: MolDX: L1CAM Gene Sequencing (A55277) Retirement - Effective May 24, 2024 May 30, 2024
Billing and Coding: MolDX: Fragile X (A55241) Retirement - Effective May 23, 2024 May 30, 2024
Billing and Coding: MolDX: FANCC Genetic Testing (A55183) Retirement - Effective May 21, 2024 May 30, 2024
Billing and Coding: MolDX: FDA-Approved EGFR Tests (A54422) - R6 - Effective May 30, 2024 May 30, 2024
Billing and Coding: MolDX: 9p21 Genotype Test (A55092) Retirement - Effective May 24, 2024 May 30, 2024
Local Coverage Determinations (LCDs) Finalized - Effective July 7, 2024 May 23, 2024
MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic Services (A59743) - R1 - Effective May 23, 2024 May 23, 2024
Billing and Coding: MolDX: HAX1 Gene Sequencing (A55249) Retirement - Effective May 14, 2024 May 23, 2024
MolDX: Blood Product Molecular Antigen Typing (L38331) - R4 - Effective May 23, 2024 May 23, 2024
Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) Testing (A55088) Retirement - Effective May 14, 2024 May 23, 2024
Billing and Coding: MolDX: HEXA Gene Analysis (A55255) Retirement - Effective May 8, 2024 May 16, 2024